BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 28870971)

  • 1. Polygenic determinants in extremes of high-density lipoprotein cholesterol.
    Dron JS; Wang J; Low-Kam C; Khetarpal SA; Robinson JF; McIntyre AD; Ban MR; Cao H; Rhainds D; Dubé MP; Rader DJ; Lettre G; Tardif JC; Hegele RA
    J Lipid Res; 2017 Nov; 58(11):2162-2170. PubMed ID: 28870971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence of a polygenic origin of extreme high-density lipoprotein cholesterol levels.
    Motazacker MM; Peter J; Treskes M; Shoulders CC; Kuivenhoven JA; Hovingh GK
    Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1521-8. PubMed ID: 23685560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe hypertriglyceridemia is primarily polygenic.
    Dron JS; Wang J; Cao H; McIntyre AD; Iacocca MA; Menard JR; Movsesyan I; Malloy MJ; Pullinger CR; Kane JP; Hegele RA
    J Clin Lipidol; 2019; 13(1):80-88. PubMed ID: 30466821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mining the LIPG allelic spectrum reveals the contribution of rare and common regulatory variants to HDL cholesterol.
    Khetarpal SA; Edmondson AC; Raghavan A; Neeli H; Jin W; Badellino KO; Demissie S; Manning AK; DerOhannessian SL; Wolfe ML; Cupples LA; Li M; Kathiresan S; Rader DJ
    PLoS Genet; 2011 Dec; 7(12):e1002393. PubMed ID: 22174694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2019 George Lyman Duff Memorial Lecture: Three Decades of Examining DNA in Patients With Dyslipidemia.
    Hegele RA; Dron JS
    Arterioscler Thromb Vasc Biol; 2020 Sep; 40(9):1970-1981. PubMed ID: 32762461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Six years' experience with LipidSeq: clinical and research learnings from a hybrid, targeted sequencing panel for dyslipidemias.
    Dron JS; Wang J; McIntyre AD; Iacocca MA; Robinson JF; Ban MR; Cao H; Hegele RA
    BMC Med Genomics; 2020 Feb; 13(1):23. PubMed ID: 32041611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted next-generation sequencing to diagnose disorders of HDL cholesterol.
    Sadananda SN; Foo JN; Toh MT; Cermakova L; Trigueros-Motos L; Chan T; Liany H; Collins JA; Gerami S; Singaraja RR; Hayden MR; Francis GA; Frohlich J; Khor CC; Brunham LR
    J Lipid Res; 2015 Oct; 56(10):1993-2001. PubMed ID: 26255038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Sequence Variation in the Apolipoprotein A2 Gene and Their Relationship with Serum High-Density Lipoprotein Cholesterol Levels.
    Bandarian F; Daneshpour MS; Hedayati M; Naseri M; Azizi F
    Iran Biomed J; 2016; 20(2):84-90. PubMed ID: 26590203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiplexed Targeted Resequencing Identifies Coding and Regulatory Variation Underlying Phenotypic Extremes of High-Density Lipoprotein Cholesterol in Humans.
    Khetarpal SA; Babb PL; Zhao W; Hancock-Cerutti WF; Brown CD; Rader DJ; Voight BF
    Circ Genom Precis Med; 2018 Jul; 11(7):e002070. PubMed ID: 29987113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An increased burden of common and rare lipid-associated risk alleles contributes to the phenotypic spectrum of hypertriglyceridemia.
    Johansen CT; Wang J; Lanktree MB; McIntyre AD; Ban MR; Martins RA; Kennedy BA; Hassell RG; Visser ME; Schwartz SM; Voight BF; Elosua R; Salomaa V; O'Donnell CJ; Dallinga-Thie GM; Anand SS; Yusuf S; Huff MW; Kathiresan S; Cao H; Hegele RA
    Arterioscler Thromb Vasc Biol; 2011 Aug; 31(8):1916-26. PubMed ID: 21597005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Contribution of GWAS Loci in Familial Dyslipidemias.
    Ripatti P; Rämö JT; Söderlund S; Surakka I; Matikainen N; Pirinen M; Pajukanta P; Sarin AP; Service SK; Laurila PP; Ehnholm C; Salomaa V; Wilson RK; Palotie A; Freimer NB; Taskinen MR; Ripatti S
    PLoS Genet; 2016 May; 12(5):e1006078. PubMed ID: 27227539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic lipase (LIPC) sequencing in individuals with extremely high and low high-density lipoprotein cholesterol levels.
    Pirim D; Bunker CH; Hokanson JE; Hamman RF; Demirci FY; Kamboh MI
    PLoS One; 2020; 15(12):e0243919. PubMed ID: 33326441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dense genotyping of candidate gene loci identifies variants associated with high-density lipoprotein cholesterol.
    Edmondson AC; Braund PS; Stylianou IM; Khera AV; Nelson CP; Wolfe ML; Derohannessian SL; Keating BJ; Qu L; He J; Tobin MD; Tomaszewski M; Baumert J; Klopp N; Döring A; Thorand B; Li M; Reilly MP; Koenig W; Samani NJ; Rader DJ
    Circ Cardiovasc Genet; 2011 Apr; 4(2):145-55. PubMed ID: 21303902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein A5 gene variants are associated with decreased adiponectin levels and increased arterial stiffness in subjects with low high-density lipoprotein-cholesterol levels.
    Kim M; Kim M; Yoo HJ; Bang YJ; Lee SH; Lee JH
    Clin Genet; 2018 Nov; 94(5):438-444. PubMed ID: 30132804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rare LPL gene variants attenuate triglyceride reduction and HDL cholesterol increase in response to fenofibric acid therapy in individuals with mixed dyslipidemia.
    Gao F; Ballantyne C; Ma L; Virani SS; Keinan A; Brautbar A
    Atherosclerosis; 2014 Jun; 234(2):249-53. PubMed ID: 24704626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SCARB1 Gene Variants Are Associated With the Phenotype of Combined High High-Density Lipoprotein Cholesterol and High Lipoprotein (a).
    Yang X; Sethi A; Yanek LR; Knapper C; Nordestgaard BG; Tybjærg-Hansen A; Becker DM; Mathias RA; Remaley AT; Becker LC
    Circ Cardiovasc Genet; 2016 Oct; 9(5):408-418. PubMed ID: 27651445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Genetics in Cardiovascular Risk Reduction: Findings From a Single Lipid Clinic and Review of the Literature.
    Benes LB; Brummell K; Roth M; Shen L; Davidson MH
    Cardiovasc Revasc Med; 2020 Feb; 21(2):200-204. PubMed ID: 31153847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Combined Effect of Common Genetic Risk Variants on Circulating Lipoproteins Is Evident in Childhood: A Longitudinal Analysis of the Cardiovascular Risk in Young Finns Study.
    Buscot MJ; Magnussen CG; Juonala M; Pitkänen N; Lehtimäki T; Viikari JS; Kähönen M; Hutri-Kähönen N; Schork NJ; Raitakari OT; Thomson RJ
    PLoS One; 2016; 11(1):e0146081. PubMed ID: 26731281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic determinants of plasma HDL-cholesterol levels in familial hypercholesterolemia.
    van Aalst-Cohen ES; Jansen AC; Boekholdt SM; Tanck MW; Fontecha MR; Cheng S; Li J; Defesche JC; Kuivenhoven JA; Kastelein JJ
    Eur J Hum Genet; 2005 Oct; 13(10):1137-42. PubMed ID: 16030523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic contribution of SCARB1 variants to lipid traits in African Blacks: a candidate gene association study.
    Niemsiri V; Wang X; Pirim D; Radwan ZH; Bunker CH; Barmada MM; Kamboh MI; Demirci FY
    BMC Med Genet; 2015 Nov; 16():106. PubMed ID: 26563154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.